Abstract
The inhibition of differentiation and persistence of proliferation in cell transformation is probably not only caused by the mutation of single genes. An additional mechanism of transcriptional control, not only of single genes but of gene programs, is possibly the alteration of the topoisomerases. These enzymes regulate the conformation of DNA by twisting and unwinding the double strands. As has been shown previously, only the genes located in relaxed DNA areas are transcribed and, therefore, the topoisomerases can be described as a gene regulation device. We present the hypothesis that topoisomerase II action is not only altered in, but also necessary for, HL-60 granulocytic cell differentiation. Thus, alteration of topoisomerases may well be a molecular mechanism of cellular differentiation.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Castora F. J., Kelly W. G. ATP inhibits nuclear and mitochondrial type I topoisomerases from human leukemia cells. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1680–1684. doi: 10.1073/pnas.83.6.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Darby M. K., Herrera R. E., Vosberg H. P., Nordheim A. DNA topoisomerase II cleaves at specific sites in the 5' flanking region of c-fos proto-oncogenes in vitro. EMBO J. 1986 Sep;5(9):2257–2265. doi: 10.1002/j.1460-2075.1986.tb04493.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Epstein R. J. Topoisomerases in human disease. Lancet. 1988 Mar 5;1(8584):521–524. doi: 10.1016/s0140-6736(88)91308-6. [DOI] [PubMed] [Google Scholar]
- Gieseler F., Meyer P., Schiffmann D., Wilms K. Granulocytic differentiation of HL-60 cells is not regulated by DNA de novo methylation. Blut. 1989 Mar;58(3):159–163. doi: 10.1007/BF00320438. [DOI] [PubMed] [Google Scholar]
- Kohn K. W., Pommier Y., Kerrigan D., Markovits J., Covey J. M. Topoisomerase II as a target of anticancer drug action in mammalian cells. NCI Monogr. 1987;(4):61–71. [PubMed] [Google Scholar]
- Osheroff N. Eukaryotic topoisomerase II. Characterization of enzyme turnover. J Biol Chem. 1986 Jul 25;261(21):9944–9950. [PubMed] [Google Scholar]
- Riou J. F., Multon E., Vilarem M. J., Larsen C. J., Riou G. In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene. Biochem Biophys Res Commun. 1986 May 29;137(1):154–160. doi: 10.1016/0006-291x(86)91189-7. [DOI] [PubMed] [Google Scholar]
- Tan K. B., Mattern M. R., Boyce R. A., Schein P. S. Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7668–7671. doi: 10.1073/pnas.84.21.7668. [DOI] [PMC free article] [PubMed] [Google Scholar]